Zwischen Pharmazie und Radiologie

Publikationen

Development of an anthropomorphic spine phantom suitable for fusion of MR neurography with interventional flat-panel CT

Kobe A., Zadory M., Hamie Q.M., Froehlich J. M., Klarhöfer M., Elsässer T., Pfammatter T., Guggenberger R.
Eur. J. Radiol., vol. 112, pp. 153–160, Mar. 2019, doi: 10.1016/j.ejrad.2019.01.019.

 

In vitro qualitative and quantitative CT assessment of iodinated aerosol nasal deposition using a 3D-printed nasal replica

Sartoretti T., Mannil M., Biendl s., Froehlich J. M., Alkadhi H., Zadory M.
Eur. Radiol. Exp., vol. 3, no. 1, p. 32, Aug. 2019, doi: 10.1186/s41747-019-0113-6.

 

Gadolinium distribution in cerebrospinal fluid after administration of a gadolinium-based MR contrast agent in humans

Berger F., Kubik-Huch R. A., Niemann T., Schmid H. R., Poetzsch M., Froehlich J. M., Beer J. H., Thali M. J., Kraemer T.
Radiology, vol. 288, no. 3, pp. 703–709, Sep. 2018, doi: 10.1148/radiol.2018171829.

 

Functional and targeted lymph node imaging in prostate cancer: Current status and future challenges

Thoeny H. C., Barbieri S., Froehlich J. M., Turkbey B., Choyke P. L.
Radiology, vol. 285, no. 3. Radiological Society of North America Inc., pp. 728–743, Dec. 01, 2017, doi: 10.1148/radiol.2017161517.

 

Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?

Froehlich J. M., Triantafyllou M., Fleischmann A., Vermathen P., Thalmann G. N., Thoeny H. C.
Contrast Media Mol. Imaging, vol. 7, no. 3, pp. 346–355, May 2012, doi: 10.1002/cmmi.503.

 

Feasibility of small bowel flow rate measurement with MRI

Gutzeit A., Patak M. A., von Weymarn C., Graf N., Doert A., Willemse E., Binkert C. A., Froehlich J. M.
Magn. Reson. Imaging, vol. 32, no. 2, pp. 345–351, Aug. 2010, doi: 10.1002/jmri.22254.

Pharmacokinetics and pharmacodynamics of nasally delivered midazolam

Haschke M., Suter K., Hofmann S., Witschi R., Fröhlich J., Imanidis G., Drewe J., Briellmann T. A., Dussy F. E., Krähenbühl S., Surber C.
Br. J. Clin. Pharmacol., vol. 69, no. 6, pp. 607–616, 2010, doi: 10.1111/j.1365-2125.2010.03611.x.

 

Multicenter trial: Comparison of two different formulations and application systems of low-dose nasal midazolam for routine magnetic resonance imaging of claustrophobic patients

Tschirch F.T., Suter K., Froehlich J. M., Studler U., Nidecker A., Eckhardt B., Beranek-Chiu J., Surber C., Weishaupt D.
Magn. Reson. Imaging, vol. 28, no. 4, pp. 866–872, Oct. 2008, doi: 10.1002/jmri.21552.

 

Low-dose intranasal versus oral midazolam for routine body MRI of claustrophobic patients

Tschirch FT., Göpfert K., Fröhlich JM., Brunner G., Weishaupt D.
Eur. Radiol., vol. 17, no. 6, pp. 1403–1410, Jun. 2007, doi: 10.1007/s00330-006-0457-1.

 

Small bowel motility assessment with magnetic resonance imaging

Froehlich J. M., Patak M. A., von Weymarn C., Juli C. F., Zollikofer C. L., Wentz K. U.
Magn. Reson. Imaging, vol. 21, no. 4, pp. 370–375, Apr. 2005, doi: 10.1002/jmri.20284.

 

Auszeichnungen

Poster prize «summa cum laude»:

An MRI-guided HIFU-triggered wax-coated capsule for supertargeted drug release
Würthinger et al., Swiss Radiology Congress, St. Gallen 2019

 

Prize for best poster in Pharmaceutical Technology:

An MRI-guided HIFU-triggered wax-coated capsule for supertargeted drug release.
Romagna et al., Swiss Pharma Science Day, Bern 2018